CTAs are almost max long in equities, have very limited room to buy: UBS
Investing.com - Apollo Medical reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Apollo Medical announced earnings per share of $0.56 on revenue of $317M. Analysts polled by Investing.com EPS of $0.44 on revenue of $301.88M.
Apollo Medical 's are down 54% and is trading at $33.23 , still down 75.06% from its 52 week high of $133.23 set on Monday, November 15, 2021.
Apollo Medical follows other major Healthcare sector earnings this month
Apollo Medical's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar